(Q43201051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

case report

0 references

title

Psychosis following anti-obesity treatment with rimonabant (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Tarik Ugur

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marius Bartels

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bernhard Kis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Norbert Scherbaum

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

16 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

103-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.

16 January 2020

cites work

1 reference

12 December 2020

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

12 December 2020

The stress cascade and schizophrenia: etiology and onset

1 reference

12 December 2020

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Cannabinoid physiology and pharmacology: 30 years of progress.

1 reference

12 December 2020

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Endocannabinoid signaling system and brain reward: emphasis on dopamine

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Endocannabinoids in appetite control and the treatment of obesity

1 reference

12 December 2020

Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.

1 reference

12 December 2020

Rimonabant for overweight or obesity

1 reference

12 December 2020

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

12 December 2020

Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.

1 reference

12 December 2020

The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food.

1 reference

12 December 2020

The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.

1 reference

12 December 2020

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

1 reference

12 December 2020

Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockade

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization

1 reference

12 December 2020

Vulnerability--a new view of schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1159/000122763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054169%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference